Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 2971-2975, Vol. 68, No. 5
Microbiology and Tumor Biology Center,
Karolinska Institutet, and Swedish Institute for Infectious Disease
Control, Stockholm, Sweden1; Department
of Parasitology, Institute of Tropical Medicine, University of
Tübingen, Tübingen, Germany2;
and Research Unit, Albert Schweitzer Hospital,
Lambaréné, Gabon3
Received 20 October 1999/Returned for modification 15 December
1999/Accepted 27 January 2000
The malaria parasite Plasmodium falciparum utilizes
molecules present on the surface of uninfected red blood cells (RBC)
for rosette formation, and a dependency on ABO antigens has been
previously shown. In this study, the antirosetting effect of immune
sera was related to the blood group of the infected human host. Sera from malaria-immune blood group A (or B) individuals were less prone to
disrupt rosettes from clinical isolates of blood group A (or B)
patients than to disrupt rosettes from isolates of blood group O
patients. All fresh clinical isolates and laboratory strains exhibited
distinct ABO blood group preferences, indicating that utilization of
blood group antigens is a general feature of P. falciparum
rosetting. Soluble A antigen strongly inhibited rosette formation when
the parasite was cultivated in A RBC, while inhibition by
glycosaminoglycans decreased. Furthermore, a soluble A antigen conjugate bound to the cell surface of parasitized RBC. Selective enzymatic digestion of blood group A antigen from the uninfected RBC
surfaces totally abolished the preference of the parasite to form
rosettes with these RBC, but rosettes could still form. Altogether,
present data suggest an important role for A and B antigens as
coreceptors in P. falciparum rosetting.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Blood Group A Antigen Is a Coreceptor in
Plasmodium falciparum Rosetting
*
Corresponding author. Mailing address: Microbiology and
Tumor Biology Center, Box 280, Karolinska Institutet, S-171 77 Stockholm, Sweden. Phone: 46-8-4572510. Fax: 46-8-310525. E-mail:
mats.wahlgren{at}smi.ki.se.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|